These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6214210)

  • 1. Clinical and pharmacokinetic evaluation of parenteral moxalactam in infants and children.
    Keyserling H; Feldman WE; Moffitt S; Manning N; Hollins M
    Antimicrob Agents Chemother; 1982 Jun; 21(6):898-901. PubMed ID: 6214210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of 6059-S therapy in children (author's transl)].
    Meguro H; Arimasu O; Matsueda Y; Tohgo T; Hiraiwa M; Ozawa S; Mashiko J; Fujii R
    Jpn J Antibiot; 1981 Apr; 34(4):599-607. PubMed ID: 6457168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Laboratory and clinical studies of 6059-S in pediatric field (author's transl)].
    Nishimura T; Hiromatsu K; Takashima T; Tabuki K; Takagi M
    Jpn J Antibiot; 1981 May; 34(5):800-16. PubMed ID: 6457177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children.
    Kaplan SL; Mason EO; Kvernland SJ; Loiselle EM; Feigin RD
    Pediatrics; 1983 Feb; 71(2):187-91. PubMed ID: 6218472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxalactam in the treatment of pediatric infections.
    Yogev R; Schreiber M; Gardner S; Shulman ST
    Am J Dis Child; 1982 Sep; 136(9):836-9. PubMed ID: 6214182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxalactam pharmacokinetics in children.
    Romagnoli MF; Flynn K; Siber GR; Goldmann DA
    Antimicrob Agents Chemother; 1982 Jul; 22(1):47-50. PubMed ID: 6214997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxalactam therapy for bacterial infections.
    Winston DJ; Busuttil RW; Kurtz TO; Young LS
    Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    Schaad UB; McCracken GH; Threlkeld N; Thomas ML
    J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pharmacokinetic evaluation of parental cefoxitin in infants and children.
    Feldman WE; Moffitt S; Sprow N
    Antimicrob Agents Chemother; 1980 Apr; 17(4):669-74. PubMed ID: 7396456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
    Salzer W; Pegram PS; McCall CE
    Antimicrob Agents Chemother; 1983 Apr; 23(4):565-70. PubMed ID: 6222696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of moxalactam.
    Mathisen GE; Meyer RD; Thompson JM; Finegold SM
    Antimicrob Agents Chemother; 1982 May; 21(5):780-6. PubMed ID: 6213198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pharmacokinetic evaluation of moxalactam in infants and children.
    Varghese M; Khan AJ; Quaye G; Patel U; Kumar K; Evans HE
    Chemotherapy; 1982; 28(6):417-20. PubMed ID: 6218971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, excretion, and clinical efficacy of moxalactam in pediatric patients.
    Fujii R
    Rev Infect Dis; 1982; 4 Suppl():S656-63. PubMed ID: 6218579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ
    Rev Infect Dis; 1982; 4 Suppl():S606-9. PubMed ID: 6218572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and clinical evaluation of moxalactam in infants and children.
    Latif R; Thirumoorthi MC; Buckley JA; Kobos DM; Aravind MK; Kauffman RE; Dajani AS
    Dev Pharmacol Ther; 1981; 3(4):222-31. PubMed ID: 6212231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxalactam therapy of bacterial meningitis in adults.
    Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
    De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
    Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxalactam concentration in human aqueous humor after intravenous administration.
    Axelrod JL; Kochman RS
    Arch Ophthalmol; 1982 Aug; 100(8):1334-6. PubMed ID: 6213219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental and clinical studies on 6059-S (author's transl)].
    Toyonaga Y; Sugita M; Kurosu Y; Kumagai K; Hori M; Takahashi T
    Jpn J Antibiot; 1981 May; 34(5):764-81. PubMed ID: 6457175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.